Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese

International Journal of Food Microbiology

Volumn 144, Issue 2, 2010, Pages 293-300

  Saxelin, Maija ^a   Lassig, Anna ^b   Karjalainen, Heli ^a   Tynkkynen, Soile ^a   Surakka, Anu ^a   Vapaatalo, Heikki ^c   Järvenpää, Salme ^d   Korpela, Riitta ^a,c   Mutanen, Marja ^b   Hatakka, Katja ^a  

^a VALIO LTD   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Medcare Foundation   (Finland)

Author keywords

Bifidobacterium; Food matrix; Lactobacillus; Persistence in gastrointestinal tract; Probiotic bacteria; Propionibacterium

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ADULT; ARTICLE; BACTERIAL COUNT; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BIFIDOBACTERIUM ANIMALIS; CHEESE; CONTROLLED STUDY; FECES ANALYSIS; FEMALE; GASTROINTESTINAL TRACT; HUMAN; HUMAN EXPERIMENT; INTESTINE FLORA; LACTOBACILLUS RHAMNOSUS; MALE; NORMAL HUMAN; PROPIONIBACTERIUM FREUDENREICHII; SALIVA ANALYSIS;

ADOLESCENT; ADULT; BIFIDOBACTERIUM; CAPSULES; CHEESE; FECES; FEMALE; GASTROINTESTINAL TRACT; HUMANS; LACTOBACILLUS RHAMNOSUS; MALE; MIDDLE AGED; PROBIOTICS; PROPIONIBACTERIUM; SALIVA; YOGURT; YOUNG ADULT;

BIFIDOBACTERIUM; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS; LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS; PROPIONIBACTERIUM; PROPIONIBACTERIUM FREUDENREICHII SUBSP. SHERMANII;

EID: 78649629407     PISSN: 01681605     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2010.10.009     Document Type: Article

References (50)

1. Ahlroos T., Tynkkynen S. Quantitative strain-specific detection of Lactobacillus rhamnosus GG in human faecal samples by real-time PCR. Journal of Applied Microbiology 2009, 106:506-514.
2. Alander M., Satokari R., Korpela R., Saxelin M., Vilpponen-Salmela T., Mattila-Sandholm T., von Wright A. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption. Applied and Environmental Microbiology 1999, 65:351-354.
3. Cesena C., Morelli L., Alander M., Siljander T., Tuomola E., Salminen S., Mattila-Sandholm T., Vilpponen-Salmela T., von Wright A. Lactobacillus crispatus and its nonaggregating mutant in human colonization trials. Journal of Dairy Science 2001, 84:1001-1010.
4. Christensen H.R., Larsen C.N., Kaestel P., Rosholm L.B., Sternberg C., Michaelsen K.F., Frokiaer H. Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults. FEMS Immunology and Medical Microbiology 2006, 47:380-390.
5. Collado M.C., Jalonen L., Meriluoto J., Salminen S. Protection mechanism of probiotic combination against human pathogens: in vitro adhesion to human intestinal mucus. Asia Pacific Journal of Clinical Nutrition 2006, 15:570-575.
6. De Man J.C., Rogosa M., Sharpe M.E. A medium for the cultivation of lactobacilli. Journal of Applied Bacteriology 1960, 23:130-135.
7. Dommels Y.E., Kemperman R.A., Zebregs Y.E., Draaisma R.B., Jol A., Wolvers D.A., Vaughan E.E., Albers R. Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Applied and Environmental Microbiology 2009, 75:6198-6204.
8. Fujimoto J., Matsuki T., Sasamoto M., Tomii Y., Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. International Journal of Food Microbiology 2008, 126:210-215.
9. Ghadimi D., Folster-Holst R., de Vrese M., Winkler P., Heller K.J., Schrezenmeir J. Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 2008, 213:677-692.
10. Gill H.S., Rutherfurd K.J. Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. British Journal of Nutrition 2001, 86:285-289.
11. Haarman M., Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 2006, 72:2359-2365.
12. Hartemink R., Kok B.J., Weenk G.H., Rombouts F.M. Raffinose-Bifidobacterium (RB) agar, a new selective medium for bifidobacteria. Journal of Microbiological Methods 1996, 27:33-43.
13. Hatakka K., Savilahti E., Pönkä A., Meurman J.H., Poussa T., Näse L., Saxelin M., Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. British Medical Journal 2001, 322(7298):1327.
14. Haukioja A., Loimaranta V., Tenovuo J. Probiotic bacteria affect the composition of salivary pellicle and streptococcal adhesion in vitro. Oral Microbiology and Immunology 2008, 23:336-343.
15. Heller K.J. Probiotic bacteria in fermented foods: product characteristics and starter organisms. American Journal of Clinical Nutrition 2001, 73(2 Suppl):374S-379S.
16. Kaila M., Isolauri E., Saxelin M., Arvilommi H., Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Archives of Diseases in Childhood 1995, 72:51-53.
17. Kajander K., Hatakka K., Poussa T., Färkkilä M., Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Alimentary and Pharmacological Therapy 2005, 22:387-394.
18. Kajander K., Myllyluoma E., Rajilic-Stojanovic M., Kyrönpalo S., Rasmussen M., Järvenpää S., Zoetendal E.G., de Vos W.M., Vapaatalo H., Korpela R. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Alimentary and Pharmacological Therapy 2008, 27:48-57.
19. Kankainen M., Paulin L., Tynkkynen S., von Ossowski I., Reunanen J., Partanen P., Satokari R., Vesterlund S., Hendrickx A.P., Lebeer S., De Keersmaecker S.C., Vanderleyden J., Hämäläinen T., Laukkanen S., Salovuori N., Ritari J., Alatalo E., Korpela R., Mattila-Sandholm T., Lassig A., Hatakka K., Kinnunen K.T., Karjalainen H., Saxelin M., Laakso K., Surakka A., Palva A., Salusjärvi T., Auvinen P., de Vos W.M. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proceedings of National Academy of Sciences of the United States of America 2009, 106:17193-17198.
20. Karjalainen, H., Ahlroos, T., Myllyluoma, E., Tynkkynen, S., 2010. Real-time PCR assays for strain-specific quantification of probiotic strains in human faecal samples. Unpublished.
21. Kekkonen R.A., Lummela N., Karjalainen H., Latvala S., Tynkkynen S., Järvenpää S., Kautiainen H., Julkunen I., Vapaatalo H., Korpela R. Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World Journal of Gastroenterology 2008, 14:2029-2036.
22. Klingberg T.D., Budde B.B. The survival and persistence in the human gastrointestinal tract of five potential probiotic lactobacilli consumed as freeze-dried cultures or as probiotic sausage. International Journal of Food Microbiology 2006, 109:157-159.
23. Krasse P., Carlsson B., Dahl C., Paulsson A., Nilsson A., Sinkiewicz G. Decreased gum bleeding and reduced gingivitis by the probiotic Lactobacillus reuteri. Swedish Dental Journal 2006, 30:55-60.
24. Lahtinen S.J., Gueimonde M., Ouwehand A.C., Reinikainen J.P., Salminen S.J. Comparison of four methods to enumerate probiotic bifidobacteria in a fermented food product. Food Microbiology 2006, 23:571-577.
25. Larsen C.N., Nielsen S., Kaestel P., Brockmann E., Bennedsen M., Christensen H.R., Eskesen D.C., Jacobsen B.L., Michaelsen K.F. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. European Journal of Clinical Nutrition 2006, 60:1284-1293.
26. Lievin-Le Moal V., Sarrazin-Davila L.E., Servin A.L. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics 2007, 120:e795-803.
27. Lievin-Le Moal V., Servin A.L. The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota. Clinical Microbiology Reviews 2006, 19:315-337.
28. Lopez M., Li N., Kataria J., Russell M., Neu J. Live and ultraviolet-inactivated Lactobacillus rhamnosus GG decrease flagellin-induced interleukin-8 production in Caco-2 cells. Journal of Nutrition 2008, 138:2264-2268.
29. Maruo T., Sakamoto M., Toda T., Benno Y. Monitoring the cell number of Lactococcus lactis subsp. cremoris FC in human feces by real-time PCR with strain-specific primers designed using the RAPD technique. International Journal of Food Microbiology 2006, 110:69-76.
30. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., Tanaka R. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Applied and Environmental Microbiology 2004, 70:167-173.
31. Meurman J.H., Stamatova I. Probiotics: contributions to oral health. Oral Diseases 2007, 13:443-451.
32. Myllyluoma E., Kajander K., Mikkola H., Kyrönpalo S., Rasmussen M., Kankuri E., Sipponen P., Vapaatalo H., Korpela R. Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Digestive and Liver Diseases 2007, 39:516-523.
33. Myllyluoma E., Veijola L., Ahlroos T., Tynkkynen S., Kankuri E., Vapaatalo H., Rautelin H., Korpela R. Probiotic supplementation improves tolerance to Helicobacter pylori eradication therapy - a placebo-controlled, double-blind randomized pilot study. Alimentary and Pharmacological Therapy 2005, 21:1263-1272.
34. Mättö J., Fonden R., Tolvanen T., von Wright A., Vilpponen-Salmela T., Satokari R., Saarela M. Intestinal survival and persistence of probiotic Lactobacillus and Bifidobacterium strains administered in triple-strain yogurt. International Dairy Journal 2006, 16:1174-1180.
35. Näse L., Hatakka K., Savilahti E., Saxelin M., Pönkä A., Poussa T., Korpela R., Meurman J.H. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Research 2001, 35:412-420.
36. Ouwehand A.C., Isolauri E., Kirjavainen P.V., Tölkkö S., Salminen S.J. The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus. Letters in Applied Microbiology 2000, 30:10-13.
37. Petschow B.W., Talbott R.D. Growth promotion of Bifidobacterium species by whey and casein fractions from human and bovine milk. Journal of Clinical Microbiology 1990, 28:287-292.
38. Requena T., Burton J., Matsuki T., Munro K., Simon M.A., Tanaka R., Watanabe K., Tannock G.W. Identification, detection and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Applied and Environmental Microbiology 2002, 68:2420-2427.
39. Rinttilä T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. Journal of Applied Microbiology 2004, 97:1166-1177.
40. Rochet V., Rigottier-Gois L., Ledaire A., Andrieux C., Sutren M., Rabot S., Mogenet A., Bresson J.-L., Cools S., Picard C., Goupil-Feuillerat N., Doré J. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilised form or in fermented product - a randomised study in healthy adults. Journal of Molecular Microbiology and Biotechnology 2008, 14:128-136.
41. Saxelin M. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective. Clinical Infectious Diseases 2008, 46(Suppl 2):S76-79.
42. Saxelin M., Ahokas M., Salminen S. Dose response on the faecal colonization of Lactobacillus strain GG administered in two different formulations. Microbial Ecology in Health and Disease 1993, 6:119-122.
43. Saxelin M., Elo S., Salminen S., Vapaatalo H. Dose response colonization of faeces after oral administration of Lactobacillus casei strain GG. Microbial Ecology in Health and Disease 1991, 4:209-214.
44. Saxelin, M., Tynkkynen, S., Salusjärvi, T., Kajander, K., Myllyluoma, E., Mattila-Sandholm, T., Korpela, R., in press. Developing a multispecies probiotic combination. International Journal of Probiotics and Prebiotics.
45. Saxelin M., Pessi T., Salminen S. Fecal recovery following oral administration of Lactobacillus strain GG (ATCC 53103) in gelatine capsules to healthy volunteers. International Journal of Food Microbiology 1995, 25:199-203.
46. Sharp M.D., McMahon D.J., Broadbent J.R. Comparative evaluation of yogurt and low-fat cheddar cheese as delivery media for probiotic Lactobacillus casei. Journal of Food Science 2008, 73:M375-377.
47. Ventura M., Reniero R., Zink R. Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Applied and Environmental Microbiology 2001, 67:2760-2765.
48. Voltan S., Castagliuolo I., Elli M., Longo S., Brun P., D'Inca R., Porzionato A., Macchi V., Palu G., Sturniolo G.C., Morelli L., Martines D. Aggregating phenotype in Lactobacillus crispatus determines intestinal colonization and TLR2 and TLR4 modulation in murine colonic mucosa. Clinical and Vaccine Immunology 2007, 14:1138-1148.
49. von Ossowski I., Reunanen J., Satokari R., Vesterlund S., Kankainen M., Huhtinen H., Tynkkynen S., Salminen S., de Vos W.M., Palva A. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Applied and Environmental Microbiology 2010, 76:2049-2057.
50. Yli-Knuuttila H., Snäll J., Kari K., Meurman J.H. Colonization of Lactobacillus rhamnosus GG in the oral cavity. Oral Microbiology and Immunology 2006, 21:129-131.